Labs / CDMO: development & manufacturing

Corat Therapeutics
Braunschweig, Germany · corat-therapeutics.com
GMP
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
CORAT Therapeutics GmbH develops fully human neutralizing antibody therapeutics against COVID-19. The company is based in Braunschweig, Germany, and focuses on antibody discovery, development, and clinical translation of SARS-CoV-2-directed products.
Their website has a general contact form; we send your quote request through it.
What they offer
Antibody discovery by phage display
Isolates human monoclonal antibodies from human antibody libraries using antibody phage display.
Lead antibody selection
Screens more than 700 SARS-CoV-2 antibody candidates to identify lead molecules with desired drug properties.
Therapeutic antibody development
Develops fully human neutralizing antibodies as investigational COVID-19 therapeutics.
Combination antibody therapy development
Develops product candidates either as stand-alone treatments or as combination therapy.
GMP-compliant production coordination
Completed GMP-compliant production of COR-101 through contracted companies.
Clinical research advancement
Advances antibody candidates from discovery into first clinical trial.
What they work on
- Modalities
- Antibody, Bispecific
- Species and models
- hamster COVID-19 model, human antibody gene libraries, blood from healthy donors, blood from convalescent COVID-19 patients
- Assays and studies
- phage display screening, SARS-CoV-2 spike protein binding selection, neutralization screening
- Therapeutic areas
- COVID-19, infectious disease
- Sites
- Braunschweig, Germany
- Founded
- 2004
Similar labs. Probiocdmo, Sparx BIO, Alphalyse, Asimov
Found in a contract services directory. Listing built from corat-therapeutics.com. Work here? Claim this listing.